Clinical Trial Update: A Phase 1/2 Crossover Study to Assess EXP039 for Myopia or Hyperopia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 crossover trial evaluating EXP039 for myopia or hyperopia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperopia
• Myopia

Drugs mentioned

• EXP039

Snippet

Sponsor: Canyon City Eyecare | Conditions: Hyperopia, Myopia | Phase 1, Phase 2 | Status: UNKNOWN